Microsoft CEO Satya Nadella announced the launch of DXGPT, an AI-powered tool to help healthcare workers diagnose and plan treatments. The instrument promises improved efficiency and accuracy in patient management. Lying photo of Microsoft CEO Satya Nadella spoke on April 16 at the 50th anniversary in Redmond, Washington, on April 16. Satya Nadella has announced new updates for the Azure Openai Foundry, which he called a ‘jump forward’ in AI reasoning technology. (Photographer: David Ryder / Bloomberg) Satya Nadella, CEO and chairman of Microsoft, announced the launch of DXGPT, a new AI-powered tool designed to help health care staff with diagnosis, treatment planning and patient care. According to Microsoft, the instrument is expected to make the way doctors and healthcare workers manage patients, the process of diagnosing and planning treatments will make treatments more efficient and accurate. What is DXGPT and how it works according to a blog post of Microsoft, DXGPT is an advanced AI system that helps doctors and medical staff make better decisions by supporting disease diagnosis and treatment options. The instrument uses large amounts of medical data and advanced technology to help healthcare workers judge symptoms, understand patients’ history and represent possible diagnoses. It is meant to work with doctors, not replace it, making it easier for medical experts to make informed decisions. The project was created by Isla, a father whose personal experiences with his child’s medical needs inspired him to develop this instrument. Isla worked hard to create a solution that helps both patients and families dealing with complicated medical problems. Support from Microsoft Microsoft played an important role in the development of DXGPT. The company gave the team of technology and advice on compliance with health care regulations. Microsoft also gave the foundation an annual award from Azure Services, which helped the team scale and improved the instrument. Plans for the future now that DXGPT is live, Isla and his team are planning to expand its use. Their first goal is to introduce it to more healthcare systems in Europe. They also intend to make DXGPT available on Microsoft’s Azure Marketplace, allowing healthcare providers around the world to access the tool in their practices. This will make it easier for doctors and medical experts worldwide to take advantage of AI-driven support for diagnosis. Story behind DXGPT The creation of DXGPT is deeply personal for Isla. His son, Sergio, who is now 16, cannot speak and constantly needs care because of his medical condition. Although Sergio may not fully understand his father’s work, Isla’s motivation to develop this instrument comes from his own experiences as a parent who faces difficult medical challenges. “We have turned a personal problem into something that can help others,” Isla said. “It fills you with satisfaction. It is rewarding to do something for others. ‘ DXGPT is now available for use in healthcare, and Isla’s work helps families experiencing similar battle. The future of the instrument depends on how wide it is adopted and the impact it has on health care practices around the world. First published: 22 Apr 2025, 23:45 IST
DXGPT goes live: Satya Nadella displays the potential of the AI instrument in the diagnosis of rare diseases | Mint
